Physician profile
Rahul Subbarayan
NPI 1801281415
$2,034.74
in general payments reported to CMS, 2019-2025
7 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $999 · 2022: $305 · 2023: $93.43 · 2024: $269 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,705.30 | 2021-2025 | Inspire |
| Acclarent, INC | $105.89 | 2021-2023 | Acclarent Aera |
| Aerin Medical INC. | $63.40 | 2022 | |
| Stryker Corporation | $58.76 | 2025 | Scopis Ent |
| Medtronic, INC. | $47.13 | 2023-2024 | Sinuva, Propel |
| Glaxosmithkline, LLC. | $33.60 | 2023 | Nucala |
| Phathom Pharmaceuticals, INC. | $20.66 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Subbarayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.